RPG Life Sciences: Dividend Tax Rules for FY26 Explained

RPG Life Sciences has communicated to its shareholders regarding the taxation provisions for the final dividend recommended for FY 2025-26. The dividend, if approved at the AGM, will be subject to TDS (Tax Deducted at Source) as per the Income Tax Act, 2025. The tax rate will vary based on the shareholder's residential status and submitted documentation. Resident shareholders will generally face a 10% TDS, with exemptions for individuals if the dividend doesn't exceed ₹10,000. Specific forms and documentation are required for tax exemption claims by different shareholder categories. Shareholders are urged to update their PAN, residential status, and other details with their depository participants or the RTA.